SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ADMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 103.25M
March 31, 2026 98.86M
December 31, 2025 96.42M
September 30, 2025 96.37M
June 30, 2025 92.91M
March 31, 2025 87.09M
December 31, 2024 78.37M
September 30, 2024 70.00M
June 30, 2024 65.61M
March 31, 2024 63.64M
December 31, 2023 63.29M
September 30, 2023 66.05M
June 30, 2023 68.61M
March 31, 2023 68.92M
December 31, 2022 70.30M
September 30, 2022 67.11M
June 30, 2022 63.23M
March 31, 2022 60.58M
December 31, 2021 55.19M
September 30, 2021 48.69M
June 30, 2021 45.15M
March 31, 2021 41.49M
December 31, 2020 37.65M
September 30, 2020 35.38M
June 30, 2020 32.70M
Date Value
March 31, 2020 29.80M
December 31, 2019 27.62M
September 30, 2019 29.98M
June 30, 2019 29.65M
March 31, 2019 27.98M
December 31, 2018 26.74M
September 30, 2018 22.53M
June 30, 2018 19.39M
March 31, 2018 18.82M
December 31, 2017 18.09M
September 30, 2017 16.19M
June 30, 2017 13.78M
March 31, 2017 11.06M
December 31, 2016 8.495M
September 30, 2016 7.096M
June 30, 2016 7.395M
March 31, 2016 7.108M
December 31, 2015 6.746M
September 30, 2015 5.974M
June 30, 2015 4.931M
March 31, 2015 5.035M
December 31, 2014 4.824M
September 30, 2014 4.710M
June 30, 2014 5.178M
March 31, 2014 5.267M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Erasca, Inc. 41.80M
Vericel Corp. 180.98M
Emergent BioSolutions, Inc. 181.20M
Exelixis, Inc. 533.92M
Krystal Biotech, Inc. 159.89M